Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 527 results found. Search for [ covid-19 human trials ]

Results 20 to 40 of 527
BusinessToday.In
April 19, 2021
The Pune-headquartered company had received approval in December last year to start phase 1 and 2 trials for its COVID-19 vaccine candidate.


BusinessToday.In
April 19, 2021
Jubilant Pharma says oral formulation is an affordable, more convenient, easy-to-administer and potentially effective treatment option for COVID-19 patients


BusinessToday.In
April 19, 2021
For this trial, the researchers are looking for 64 previously infected Covid-19 individuals between the age group 18 -30 years. The volunteers will be first reinfected with the original strain from ,China and will be monitored for a year


BusinessToday.In
April 13, 2021
India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year


BusinessToday.In
April 9, 2021
The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study.


BusinessToday.In
April 5, 2021
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.


BusinessToday.In
March 16, 2021
Share of Gland Pharma touched an all-time high of Rs 2,784.45, rising 9.54% against previous close of Rs 2,541 on BSE


BusinessToday.In
March 16, 2021
COVID-19 vaccine: Gland Pharma said that the production of Sputnik V is expected to commence from third quarter of 2021 for estimated delivery starting from fourth quarter of 2021


Reuters
March 16, 2021
The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the shot in the United States


BusinessToday.In
March 10, 2021
Deal was signed last week. Apart from India, SII is providing Covishield to several poor nations through COVAX facility being led by Gavi, Vaccine Alliance, World Health Organisation, Coalition for Epidemic Preparedness Innovations, and others


BusinessToday.In
March 2, 2021
As senior citizens across the country take part in the vaccination drive, here is all the information they need two know about the two vaccines - Covaxin and Covishield


BusinessToday.In
February 20, 2021
Russia has already approved two COVID-19 vaccines, Sputnik V and EpiVacCorona, which were also granted approval before seeing any late-stage trial results


BusinessToday.In
February 19, 2021
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.


Reuters
February 18, 2021
Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil


BusinessToday.In
February 15, 2021
Earlier, Dr Reddy's had said it expects to roll out Sputnik V vaccine in India in March via Emergency Use Authorisation (EUA) after the completion of Phase 3 trials.


BusinessToday.In
February 5, 2021
Cadila says its business in India, which comprises human health formulations, consumer wellness and animal health, posted strong growth during the quarter as it rose 20 per cent on a y-o-y basis and recorded revenues of Rs 1,643 crore


BusinessToday.In
February 3, 2021
Earlier, The Lancet had stated that Russia's experimental COVID-19 vaccine Sputnik V is 91.6 per cent affective against coronavirus infection. These results are based on Phase 3 trials of the vaccine in which 20,000 people had participated


BusinessToday.In
February 2, 2021
The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors - recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).


BusinessToday.In
February 2, 2021
Mahindra shared a snippet of information which claimed that a small biotech firm in West Sussex, England is working on putting a COVID-19 vaccine into a simple pill


Reuters
January 30, 2021
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI's links to the People's Liberation Army (PLA) include research with China's top military supercomputing experts


PAGES 2 OF 27  12345